Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy
4 minutes
Posted Sep 30, 2025 at 5:53 pm.
0:00
4:26
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Durable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.
Previous
Eye on the Cure Podcast | Episode 92: Lance Baldo, MD
Next
Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial
← See all 261 episodes of Foundation Fighting Blindness
